Court Order Could Tip Delaware Case in Abbott’s Favor

Last Friday’s ruling by a federal court in Washington, D.C., against Alere’s Arriva Medical subsidiary could help persuade the Delaware Chancery Court to allow Abbott Laboratoriesfeatured

Corrected: Judge Promises to Protect Alere from Impending Drop-Dead Date

Revised at 1:56pm EST – The Delaware Chancery Court has set aside six days at the end of April for a trial to determine whether Abbott Laboratories can walk away from its acquisition of Alere, which would brush upfeatured

Judge Plans April Trial Over Alere/Abbott Break-Up

A Delaware judge rejected pleas by Alere Inc. to schedule a fast trial over the company’s efforts to salvage its $5.8 billion acquisition by Abbott Laboratories, siding instead with Abbott’s request for an April court date. Alere had asked the court for an expedited trial beginningfeatured

Abbott Says Suit Not Aimed at Breaking Alere Deal

Abbott Laboratories said a new suit seeking confidential legal and regulatory information from Alere is not an attempt to break the companies’ $5.4 billion merger, even as the companies accelerate toward a January court date that could do just that. “The objective of the (new) lawsuit is to obtain important information before the transaction is … Read Morefeatured

Abbott and Alere Move Toward Trial

Lawyers for Abbott Laboratories and Alere prepared for trial last week, even as the two companies continued to work with a court-ordered mediator to resolve differences over the $5.8 billion merger agreement. The Delaware Chancery Court set schedules last week requiring thatfeatured

Judge Could Give Go Ahead to Alere Merger Suit

A Delaware judge is expected to clear the way for Alere to pursue its suit compelling Abbott Laboratories to speed its work obtaining regulatory approvals for its $5.8 billion acquisition of Alere. Both companies have asked Vice Chancellor Samuel Glasscock to lift a September 2 stay on the suit and allow the companies tofeatured

Abbott and Alere Slow to the Mediation Table

More than two weeks after a state judge directed the two sides to resolve their differences over their merger pact, Abbott Laboratories and Alere Inc. are still unable to agree to a mediator, increasing the likelihood that the troubled deal goes back to court. Abbott recently proposed two former Delaware judges to mediate, but Alere … Read Morefeatured

Williams and Energy Transfer Continue Battle Over Failed Merger

The Williams Companies and Energy Transfer Equity LP are asking a Delaware court to assess blame and break-up fees over the failed merger of the energy pipeline companies. In documents filed this week Williams is asking the Delaware Chancery Court to assess ETE a $410 million fee that Williams saysfeatured

Delaware Judge Directs Abbott and Alere to Work out Differences

Updated 11:07am EST – Delaware Vice Chancellor Samuel Glasscock Friday morning said that he will agree to Alere’s request for an expedited trial over its troubled merger with Abbott Laboratories, but immediately stayed his ruling and directed the companies to negotiate a settlement on their own. Alere has asked the Delaware court to compel Abbott … Read Morepublic

Alere Faces High Bar in Abbott Lawsuit

Alere Inc., which is facing two federal criminal probes and also questions about its financial statements, has accused merger partner Abbott Laboratories of trying to scuttle their merger agreement because of “buyer’s remorse,” according to a lawsuit filed by Alere in Delaware Chancery Court and made public Wednesday. The Waltham, Massachusetts-based medical device maker also … Read Morefeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.